openPR Logo
Press release

Cytokine Based Therapies and Inhibitors Market | Current and Future Trends, 2025

03-05-2018 01:58 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Cytokine Based Therapies and Inhibitors Market | Current

Cytokines are produced by broad range of cells including cells of immune system of human body with respect to complex immune responses. Cytokines aid in intercellular communication in immune response because they are cell signaling molecules and trigger the movement of cells toward sites of inflammation, infection and trauma. Cytokines can be categorized as peptides, proteins, and glycoproteins. Cytokines and their receptors are used in various treatment therapies for inflammatory and immune disorders, infectious diseases (such as HIV and HCV), and oncology; due to their ability to boost immune responses.

Get Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3234

The market for cytokine based therapies and inhibitors has impressive growth prospects, majorly due to multi-faceted use of cytokines in diagnostic, therapeutic, and prophylactic applications and increased feasibility of chemical synthesis of cytokines. On the contrary, factors such as short half-lives of drug, lack of target-specific treatment and technical expertise, high cost involved in new product development, and high therapy cost may restrain the market for cytokines in the next few years. Cytokines have inherently short half-life, which necessitates prolonged administration of cytokine therapies. This is a major problem in maintaining an effective dose over a long period. This becomes even greater issue when cytokine is administered systematically. In the meantime, cancer immunotherapy has progressed in the area of specificity, where the cytokine therapy cannot possibly improve. This is perhaps the biggest drawback of the cytokine therapy. Development of cytokine-based therapies offers lucrative growth opportunities to market players, as it is one of the prominent areas of immunotherapies. Roche Diagnostics, Immunochemistry Technologies LLC, and Merck/Schering Plough are some of the companies operating in the immunotherapies market.

The global cytokine based therapies and inhibitors market has been segmented in terms of cytokine type, therapeutic application, and geography. In terms of cytokine type, the market has been segmented into tumor necrosis factor (anti-TNF drugs), interleukins (IL), interferon (IFN), epidermal growth factor (EGF), and chemokine. Based on therapeutic application, the market has been categorized into cancer & malignancies, inflammatory & immune disorders (asthma/airway inflammation, arthritis), infectious diseases (such as HIV and HCV), and others. In terms of geography, the global cytokines market has been segmented into North America, Europe, Asia Pacific, and Rest of World.

Request Report For TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3234

Interferons are induced in response to viral infections. INTRON A (Merck Sharp & Dohme Corp.) and Pegasys (Genentech, Inc.) are some of the approved brands of cytokine interferon. Tumor necrosis factors are basically involved in the regulation of cell proliferation and apoptosis and is instrumental in genesis of liver, cachexia, and anemia by activating platelets. Anti-TNF drugs treat inflammatory conditions such as rheumatoid arthritis (RA), juvenile arthritis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), and psoriasis. These drugs block tumor necrosis factor (TNF), an inflammation-causing substance, and thereby, reduce inflammation and stop disease progression.

Major players are developing and adding cytokine drugs to their portfolios. In July 2017, Merck launched a biosimilar anti TNF drug RENFLEXIS. This drug is the second FDA approval for a biosimilar of its original biologic medicine Remicade (infliximab) developed by Johnson & Johnson. The first biosimilar was Pfizer and Celltrion’s Inflectra, which was approved in July 2016.

Enquiry for discount on this report – https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3234

Key players operating in the global cytokine based therapies and inhibitors market are AbbVie Inc., GlaxoSmithKline LLC, Eli Lilly and Company, Genentech, Inc., Roche Diagnostics, Immunochemistry Technologies LLC, Merck Sharp & Dohme Corp., Amgen Inc., Novartis, Pfizer, Johnson & Johnson, Sanofi, Teva, and Genentech, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Report Overview @ https://www.transparencymarketresearch.com/cytokine-based-therapies-inhibitors.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytokine Based Therapies and Inhibitors Market | Current and Future Trends, 2025 here

News-ID: 964855 • Views:

More Releases from Transparency Market Research

Non-Destructive Testing Market Projected to Reach $31.9 Billion by 2034: TMR Analysis
Non-Destructive Testing Market Projected to Reach $31.9 Billion by 2034: TMR Ana …
The Global Non-Destructive Testing (NDT) Market (비파괴 검사(NDT) 시장) is set to witness significant growth, projected to reach an estimated value of $31.9 billion by the end of 2034. This growth trajectory follows a valuation of $15.5 billion in 2023, fueled by a compound annual growth rate (CAGR) of 6.7% from 2024 to 2034. The increase in demand for inspection and health monitoring of concrete and steel structures is a primary
Outdoor Power Equipment Market Set to Reach $42.8 Billion by 2034, Driven by Sustainable Solutions and Growing Landscaping Demand
Outdoor Power Equipment Market Set to Reach $42.8 Billion by 2034, Driven by Sus …
The Global Outdoor Power Equipment Market (屋外用電動機器市場), valued at $30.5 billion in 2023, is projected to experience robust growth over the next decade. According to recent industry analysis, the market is expected to grow at a compound annual growth rate (CAGR) of 3.1%, reaching an estimated $42.8 billion by 2034. This growth is largely attributed to the increasing adoption of landscaping services and a rising demand for sustainable solutions in
Global Semiconductor IP Market to Reach $13.5 Billion by 2034, Growing at a 5.9% CAGR: TMR Analysis
Global Semiconductor IP Market to Reach $13.5 Billion by 2034, Growing at a 5.9% …
The Global Semiconductor Intellectual Property (IP) Market (반도체 지적재산권(IP) 시장), valued at US$ 7.1 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2034, reaching US$ 13.5 billion by the end of the forecast period. This growth is primarily fueled by increasing demand for AI-based applications across various industries and government initiatives aimed at modernizing defense technologies. Download Sample PDF from
Glass Wafer Carrier Market to Surge, Expected to Reach $2.2 Billion by 2031: TMR Analysis
Glass Wafer Carrier Market to Surge, Expected to Reach $2.2 Billion by 2031: TMR …
The Global Glass Wafer Carrier Market (ガラスウェーハキャリア市場) is poised for significant growth, expected to reach a valuation of US$ 2.2 billion by 2031, advancing at a remarkable CAGR of 19.2% from 2024. The surge in demand for semiconductors in automotive and IT & telecommunications sectors is driving this trend, positioning glass wafer carriers as critical components in semiconductor manufacturing processes. Analysts indicate that the automotive industry's increased focus on vehicle safety,

All 5 Releases


More Releases for Cytokines

Global Cytokines Market Forecast 2018-2025 Sanofi, Novartis, Biocon, Pfizer
Market Forecast Report on Top Manufacturers companies are AbbVie (USA), Johnson & Johnson (USA), GlaxoSmithKline (UK), Novartis (Switzerland), Roche (Switzerland), Pfizer (USA), Sanofi (France), Bayer HealthCare (Germany), Thermo Fisher Scientific (USA), Biocon (India), Bio-Techne (USA). Recently added detailed market study "Global Cytokines Market" examines the performance of the Cytokines market 2018. It encloses an in-depth Research of the Cytokines market state and the competitive landscape globally. This report analyzes the potential
World Cytokines Market Opportunities and Forecasts, 2017-2023
Cytokines are a broad and loose category of small proteins that are important in cell signaling. Their release has an effect on the behavior of cells around them. It can be said that cytokines are involved in autocrine signaling, paracrine signaling and endocrine signaling as immunomodulation agents. Their definite distinction from hormones is still part of ongoing research. Cytokines may include chemokines, interferons, interleukins, lymphokines, and tumor necrosis factors but
Global Cytokines Market 2018 - AbbVie, Roche, Pfizer, Sanofi, Biocon
Apex Market Reports, recently published a detailed market research study focused on the “Cytokines Market” across the global, regional and country level. The report provides 360° analysis of “Cytokines Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Cytokines on the basis of
Promising Contribution of Cytokines in Stem Cell Therapy is the current trend in …
The report “CYTOKINE MARKET”, gives the information about market size, share, growth, and industry analysis. The cytokines market is estimated to reach USD XX Billion by 2024, at a CAGR of XX% during forecast period. Cytokines are produced by cells of the immune system of human body. Cytokines are also known as cell signaling molecules which can monitor the movement of cells towards sites of inflammation, infection, and trauma. They are
Cytokines Market to Record High Demand by 2017 – 2022
Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. Their use in disease diagnosis and treatment has proven very beneficial over the past number of years as their use as biomarkers has been adopted as a means to understanding disease
Cytokines Market 2017 - AbbVie, Johnson & Johnson, GlaxoSmithKline, Sanofi
Apex Research, recently published a detailed market research study focused on the "Cytokines Market" across the global, regional and country level. The report provides 360° analysis of "Cytokines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cytokines industry, and estimates the future trend of Cytokines market on the basis of this